Beyond ferroptosis: Role of GPX4 in osteoarthritis and its therapeutic implications
Ferroptosis and Oxidative Stress · 2025
DOI: 10.70401/fos.2026.0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2025. Verfasst von Junchen He und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Osteoarthritis (OA) is increasingly regarded as a whole-organ disease that includes different subsets of joint pathological conditions with variable genetic, biochemical and clinical characteristics. The pathogenesis of OA is perplexing, and disease-modifying drugs are still lacking. Glutathione peroxidase 4 (GPX4), recently best known as the key regulator of ferroptosis implicated in many diseases, including OA, actually has long been identified and reportedly possesses multiple significant biological functions. However, the relationship between GPX4 and OA remains to be elucidated. In this review, we first summarize the current knowledge of GPX4 as a selenoenzyme and the regulation of its expression. Then we scrutinize various possible patterns of involvement of GPX4 in OA. Finally, we also underscore the potential implications and prospects of GPX4-based therapeutic regimens for OA.
Zitieren
APA
He, J., Zhang, X., Hou, L., Liu, H., Guo, F., & Sun, K. (2025). Beyond ferroptosis: Role of GPX4 in osteoarthritis and its therapeutic implications. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0013
Vancouver
He J, Zhang X, Hou L, Liu H, Guo F, Sun K. Beyond ferroptosis: Role of GPX4 in osteoarthritis and its therapeutic implications. Ferroptosis and Oxidative Stress. 2025. doi:10.70401/fos.2026.0013
BibTeX
@article{He2025,
author = {He, Junchen and Zhang, Xiong and Hou, Liangcai and Liu, Haigang and Guo, Fengjing and Sun, Kai},
title = {Beyond ferroptosis: Role of GPX4 in osteoarthritis and its therapeutic implications},
journal = {Ferroptosis and Oxidative Stress},
year = {2025},
doi = {10.70401/fos.2026.0013}
}
EUVIMED